Posted on 03/08/2021 3:59:27 PM PST by Cathi
"After the second vaccination, 31.3 % of the elderly had no detectable neutralizing antibodies in contrast to the younger group, in which only 2.2% had no detectable neutralizing antibodies."
Conclusion Our data suggests that lower frequencies of neutralizing antibodies after BNT162b2 vaccination in the elderly population may require earlier revaccination to ensure strong immunity and protection against infection."
(Excerpt) Read more at medrxiv.org ...
in baby’s English please
Correct me if I am wrong, but this sounds a lot like saying “Not as effective in the older population”.
And more is needed which in my opinion, translates into more $$$$ for the pharmas.
Darn, people need to be taught that Vitamin D3, Zinc and Magnesium will help tremendously.
The efficacy of the vaccine is age dependent. Younger people will have stronger, longer lasting protection. The elderly (in this case people over 80) will have weaker, shorter lasting protection and will need to be revaccinated more frequently according to this study.
“in baby’s English please”
Remember the two doses for Pfizer or Moderna?
If you’re elderly...make that three doses, or four, or five. After all, they ARE experimental vaccines.
Alex Berenson
@AlexBerenson
·
51m
JUST A REMINDER THAT NO HEALTH AUTHORITY - NOT IN ENGLAND, NOT IN SCOTLAND, NOT ISRAEL - HAS SEEN FIT TO PUBLISH NUMBERS OF ALL-CAUSE HOSPITALIZATIONS OR DEATHS IN A POST-VACCINATED POPULATION.
Gee, I wonder why.
8
227
704
Alex Berenson
@AlexBerenson
·
59m
4/ Again, some protection is better than none, and the over-80s reported fewer side effects. So the cost-benefit still suggests they should take it. But this is another nail in the umm coffin of the theory the vaccines are magically going to end the epidemic.
20
24
133
Show this thread
Alex Berenson
@AlexBerenson
·
1h
3/ And why a fair number of vaccinated people are still getting sick and dying. As with the flu vaccine, Come-here-naughty works great except for the people who really need it. Link:
Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
medrxiv.org
2
28
112
Show this thread
Alex Berenson
@AlexBerenson
·
1h
2/ Compared to only 2% of the younger group. And 17 days after 1 dose, only 1% of the older group (and 16% of the younger) had neutralizing antibodies.
This is the cell-level answer to the question of why Israel reported few gains into February. One dose is nearly useless...
8
32
130
Show this thread
Alex Berenson
@AlexBerenson
·
1h
1/ Wow. This is the paper I’ve been waiting for. German researchers examined how well the
@pfizer
vaccine worked in people over 80 compared to under 60.
The answer: not well at all. 17 days after the second dose - peak protection - 1/3 had NO neutralizing antibodies...
Also This: “This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.”
👍🏻👍🏻
But, but....they can safely gather, maskless, with other experimentally “vax’d” elderly peeps.
No it does not exactly mean “The efficacy of the vaccine is age dependent ... and will have to be revaccinated more frequently”
it means that in 1/3 of people over 80 this specific “vaccine” is not effective.
I think it means that they should wait until there are studies of other “vaccines” before making a choice and assuming they are protected.
Spot on.
I think they have to test seniors who actually had Covid and see what their antibodies are at.
Also This: “This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.”
*****************************************************
Party pooper! ;-)
Yes
This is common to most vaccines in elderly people. Once you pass 80 your immune system no longer behaves like it did when you were younger.
Please, speak as you might to a young child, or a golden retriever ...
That’s why normal clinical trials take years, through many phases, and require a balance of demographics and often proof of superiority or non-inferiority to existing treatments (vaccines a little different). These things were developed in weeks and tested and approved in months and compared against nothing (no treatments have been approved, some explicitly withdrawn or frowned upon leaving 20 million Americans without a treatment option). We’re bound to find out a lot more in time.
This is going well.
So much for efficacy.
No, people need to “be taught” that this virus is not that big a deal.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.